SPINAL MUSCULAR ATROPHY TYPE II

Clinical trials for SPINAL MUSCULAR ATROPHY TYPE II explained in plain language.

Never miss a new study

Get alerted when new SPINAL MUSCULAR ATROPHY TYPE II trials appear

Sign up with your email to follow new studies for SPINAL MUSCULAR ATROPHY TYPE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 2 Not yet finished but already full! 1 Completed 2

SPINRAZA study tracks movement in adults with spinal muscular atrophy

Disease control Ongoing

This study follows 20 adults with spinal muscular atrophy (SMA) type II who are already taking SPINRAZA. Researchers will measure motor function using a 32-point scale over 27 months to see if the drug helps maintain or improve movement. The goal is to better understand how SPINR…

Matched conditions: SPINAL MUSCULAR ATROPHY TYPE II

Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC

SPINAL MUSCULAR ATROPHY TYPE II

Get alerted when new SPINAL MUSCULAR ATROPHY TYPE II trials appear

SPINRAZA study tracks movement in adults with spinal muscular atrophy